# Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial

> **NCT02111161** · PHASE2 · COMPLETED · sponsor: **Anders Perner** · enrollment: 100 (actual)

## Conditions studied

- Necrotizing Soft Tissue Infection
- Necrotizing Fasciitis
- Gas Gangrene
- Fournier Gangrene

## Interventions

- **DRUG:** IVIG (Privigen)
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT02111161
- **Lead sponsor:** Anders Perner
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111161, "Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02111161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*